As the wind and rain pound the blades of a wind turbine, UBC Okanagan researcher...
Many aquifers in California and around the world are being drained of their grou...
A West Virginia University team of industrial engineers is looking to turn $800,...
Niigata, Japan – A new Japanese ecological study revealed that prefecture-specif...
Novo Nordisk, a global pharmaceutical giant renowned for its groundbreaking diab...
In a phase 2 study focused on multiple sclerosis (MS), Roche’s BTK inhibitor, Fe...
Omeros has discontinued a phase 3 trial involving narsoplimab for kidney disease...
Roche’s gene therapy arm, Spark, has made a significant stride in bolstering its...
In a significant breakthrough, Ultragenyx and Mereo’s genetic bone disease treat...
Antiverse and GlobalBio have extended their collaboration agreement to advance ...
Leucine is joining the artificial intelligence (AI) wave sweeping through the p...
Vaxcyte has signed a new commercial agreement with Lonza for the global manufac...
The US Food and Drug Administration (FDA) has granted a priority review to the ...
The United States Food and Drug Administration (FDA) has approved yet another c...
Dutch biotech firm, NorthSea Therapeutics, has seen one of its treatments for n...
